EMCURE: CANADIAN STEP-DOWN SUBSIDIARY ACQUIRES 100% CLASS E SHARES OF MANTRA PHARMA

• Step-down subsidiary Marcan Pharmaceuticals Inc. to acquire 100% of Class E Special Shares of Mantra Pharma Inc. (Canada) • Acquisition for an aggregate cash consideration of CAD 50 million • Mantra operates in the Canadian prescription drugs and natural health products market with FY26 revenue of CAD 96.67 million • Acquisition expected to be completed on July 3, 2026, subject to customary compliances

Emcure Pharmaceuticals Ltd

Open attachment

← Back to feed